 | • レポートコード：QYR9NV18151 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、黒色腫診断及び治療の世界市場について調査・分析し、黒色腫診断及び治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（結節性黒色腫、表在性悪性黒色腫、メラニン性黒色腫、その他）、用途別（病院、診断センター、医療機関、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の黒色腫診断及び治療市場動向 ・主要企業別マーケットシェア ・黒色腫診断及び治療の種類別市場規模2014-2019 （結節性黒色腫、表在性悪性黒色腫、メラニン性黒色腫、その他） ・黒色腫診断及び治療の用途別市場規模2014-2019 （病院、診断センター、医療機関、その他） ・黒色腫診断及び治療の北米市場：主要企業・種類別/用途別市場規模 ・黒色腫診断及び治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・黒色腫診断及び治療の中国市場：主要企業・種類別/用途別市場規模 ・黒色腫診断及び治療の日本国内市場：主要企業・種類別/用途別市場規模 ・黒色腫診断及び治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・黒色腫診断及び治療のインド市場：主要企業・種類別/用途別市場規模 ・黒色腫診断及び治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott、Agilent Technologies、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、GlaxoSmithKline、Merck、Novartis、Pfizer、Qiagen、Roche、Sanofi） ・黒色腫診断及び治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. The market for melanoma diagnostics and therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities.In 2018, the global Melanoma Diagnostics and Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Melanoma Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Melanoma Diagnostics and Therapeutics development in North America, Europe and Asia-Pacific.
The key players covered in this study
Abbott
Agilent Technologies
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GlaxoSmithKline
Merck
Novartis
Pfizer
Qiagen
Roche
Sanofi
Market segment by Type, the product can be split into
Nodular Melanoma
Superficial Spreading Melanoma
Amelanotic Melanoma
Others
Market segment by Application, split into
Hospital
Diagnostic Center
Medical Institution
Others
Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific
The study objectives of this report are:
To analyze global Melanoma Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Melanoma Diagnostics and Therapeutics development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Melanoma Diagnostics and Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Melanoma Diagnostics and Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Nodular Melanoma
1.4.3 Superficial Spreading Melanoma
1.4.4 Amelanotic Melanoma
1.4.5 Others
1.5 Market by Application
1.5.1 Global Melanoma Diagnostics and Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Diagnostic Center
1.5.4 Medical Institution
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Melanoma Diagnostics and Therapeutics Market Size
2.2 Melanoma Diagnostics and Therapeutics Growth Trends by Regions
2.2.1 Melanoma Diagnostics and Therapeutics Market Size by Regions (2019-2025)
2.2.2 Melanoma Diagnostics and Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Melanoma Diagnostics and Therapeutics Market Size by by Players
3.1.1 Global Melanoma Diagnostics and Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Melanoma Diagnostics and Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Melanoma Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Melanoma Diagnostics and Therapeutics Key Players Head office and Area Served
3.3 Key Players Melanoma Diagnostics and Therapeutics Product/Solution/Service
3.4 Date of Enter into Melanoma Diagnostics and Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Melanoma Diagnostics and Therapeutics Market Size by Type (2014-2019)
4.2 Global Melanoma Diagnostics and Therapeutics Market Size by Application (2014-2019)
5 North America
5.1 North America Melanoma Diagnostics and Therapeutics Market Size (2014-2019)
5.2 Melanoma Diagnostics and Therapeutics Key Players in North America
5.3 North America Melanoma Diagnostics and Therapeutics Market Size by Type
5.4 North America Melanoma Diagnostics and Therapeutics Market Size by Application
6 Europe
6.1 Europe Melanoma Diagnostics and Therapeutics Market Size (2014-2019)
6.2 Melanoma Diagnostics and Therapeutics Key Players in Europe
6.3 Europe Melanoma Diagnostics and Therapeutics Market Size by Type
6.4 Europe Melanoma Diagnostics and Therapeutics Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size (2014-2019)
7.2 Melanoma Diagnostics and Therapeutics Key Players in Asia-Pacific
7.3 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type
7.4 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application
8 International Players Profiles
8.1 Abbott
8.1.1 Abbott Company Details
8.1.2 Company Description and Business Overview
8.1.3 Melanoma Diagnostics and Therapeutics Introduction
8.1.4 Abbott Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019))
8.1.5 Abbott Recent Development
8.2 Agilent Technologies
8.2.1 Agilent Technologies Company Details
8.2.2 Company Description and Business Overview
8.2.3 Melanoma Diagnostics and Therapeutics Introduction
8.2.4 Agilent Technologies Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019)
8.2.5 Agilent Technologies Recent Development
8.3 AstraZeneca
8.3.1 AstraZeneca Company Details
8.3.2 Company Description and Business Overview
8.3.3 Melanoma Diagnostics and Therapeutics Introduction
8.3.4 AstraZeneca Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019)
8.3.5 AstraZeneca Recent Development
8.4 Bristol-Myers Squibb
8.4.1 Bristol-Myers Squibb Company Details
8.4.2 Company Description and Business Overview
8.4.3 Melanoma Diagnostics and Therapeutics Introduction
8.4.4 Bristol-Myers Squibb Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019)
8.4.5 Bristol-Myers Squibb Recent Development
8.5 Eli Lilly
8.5.1 Eli Lilly Company Details
8.5.2 Company Description and Business Overview
8.5.3 Melanoma Diagnostics and Therapeutics Introduction
8.5.4 Eli Lilly Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019)
8.5.5 Eli Lilly Recent Development
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Company Details
8.6.2 Company Description and Business Overview
8.6.3 Melanoma Diagnostics and Therapeutics Introduction
8.6.4 GlaxoSmithKline Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019)
8.6.5 GlaxoSmithKline Recent Development
8.7 Merck
8.7.1 Merck Company Details
8.7.2 Company Description and Business Overview
8.7.3 Melanoma Diagnostics and Therapeutics Introduction
8.7.4 Merck Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019)
8.7.5 Merck Recent Development
8.8 Novartis
8.8.1 Novartis Company Details
8.8.2 Company Description and Business Overview
8.8.3 Melanoma Diagnostics and Therapeutics Introduction
8.8.4 Novartis Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019)
8.8.5 Novartis Recent Development
8.9 Pfizer
8.9.1 Pfizer Company Details
8.9.2 Company Description and Business Overview
8.9.3 Melanoma Diagnostics and Therapeutics Introduction
8.9.4 Pfizer Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019)
8.9.5 Pfizer Recent Development
8.10 Qiagen
8.10.1 Qiagen Company Details
8.10.2 Company Description and Business Overview
8.10.3 Melanoma Diagnostics and Therapeutics Introduction
8.10.4 Qiagen Revenue in Melanoma Diagnostics and Therapeutics Business (2014-2019)
8.10.5 Qiagen Recent Development
8.11 Roche
8.12 Sanofi
9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific
10 Analyst’s Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details
Table Melanoma Diagnostics and Therapeutics Key Market Segments
Table Key Players Melanoma Diagnostics and Therapeutics Covered
Table Global Melanoma Diagnostics and Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Nodular Melanoma Figures
Table Key Players of Nodular Melanoma
Figuer Superficial Spreading Melanoma Figures
Table Key Players of Superficial Spreading Melanoma
Figuer Amelanotic Melanoma Figures
Table Key Players of Amelanotic Melanoma
Figuer Others Figures
Table Key Players of Others
Table Global Melanoma Diagnostics and Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Melanoma Diagnostics and Therapeutics Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Diagnostic Center Case Studies
Figure Medical Institution Case Studies
Figure Others Case Studies
Figure Melanoma Diagnostics and Therapeutics Report Years Considered
Figure Global Melanoma Diagnostics and Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Melanoma Diagnostics and Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Melanoma Diagnostics and Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Melanoma Diagnostics and Therapeutics Market Share by Regions 2014-2019
Figure Global Melanoma Diagnostics and Therapeutics Market Share by Regions 2014-2019
Figure Global Melanoma Diagnostics and Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Melanoma Diagnostics and Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Melanoma Diagnostics and Therapeutics Market Share by by Players (2014-2019)
Figure Global Melanoma Diagnostics and Therapeutics Market Share by by Players in 2018
Table Global Melanoma Diagnostics and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Melanoma Diagnostics and Therapeutics Product/Solution/Service
Table Date of Enter into Melanoma Diagnostics and Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Melanoma Diagnostics and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Melanoma Diagnostics and Therapeutics Market Size Share by Type (2014-2019)
Figure Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Melanoma Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Melanoma Diagnostics and Therapeutics Market Size Share by Application (2014-2019)
Figure Global Melanoma Diagnostics and Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Application in 2018
Figure North America Melanoma Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Melanoma Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Melanoma Diagnostics and Therapeutics Market Share (2018-2019)
Table North America Melanoma Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Melanoma Diagnostics and Therapeutics Market Share by Type 2014-2019
Table North America Melanoma Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Melanoma Diagnostics and Therapeutics Market Share by Application 2014-2019
Figure Europe Melanoma Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Melanoma Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Melanoma Diagnostics and Therapeutics Market Share (2018-2019)
Table Europe Melanoma Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Melanoma Diagnostics and Therapeutics Market Share by Type 2014-2019
Table Europe Melanoma Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Melanoma Diagnostics and Therapeutics Market Share by Application 2014-2019
Figure Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Melanoma Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Melanoma Diagnostics and Therapeutics Market Share (2018-2019)
Table Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Melanoma Diagnostics and Therapeutics Market Share by Type 2014-2019
Table Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Melanoma Diagnostics and Therapeutics Market Share by Application 2014-2019
Table Abbott Company Details
Table Abbott Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure Abbott Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table Abbott Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure Agilent Technologies Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table Agilent Technologies Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure Eli Lilly Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Melanoma Diagnostics and Therapeutics Business 2014-2019 (Million US$)
Figure Qiagen Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2014-2019)
Table Qiagen Recent Development
Table Roche Company Details
Table Sanofi Company Details
Table Global Melanoma Diagnostics and Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Melanoma Diagnostics and Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Melanoma Diagnostics and Therapeutics Market Size Share by Regions in 2025
Figure North America Melanoma Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Melanoma Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Melanoma Diagnostics and Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Melanoma Diagnostics and Therapeutics Market Size by Product (2019-2025)
Figure Global Melanoma Diagnostics and Therapeutics Market Size by Product in 2025
Table Global Melanoma Diagnostics and Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Melanoma Diagnostics and Therapeutics Market Size by Application (2019-2025)
Figure Global Melanoma Diagnostics and Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
黒色腫診断及び治療のグローバル市場：規模・現状・予測2019-2025 Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. The market for melanoma diagnostics and therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities.In 20…- 黒色腫診断及び治療のグローバル市場：規模・現状・予測2019-2025 Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. The market for melanoma diagnostics and therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities.In 20…
- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
- 転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …